Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5900
+0.0050 (0.85%)
Jun 26, 2026, 3:59 PM AEST
Aroa Biosurgery Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aroa Biosurgery stock has a consensus rating of "Strong Buy" and an average price target of $1.08. The average 1-year stock price forecast is 83.05% higher than the current stock price, while the lowest is $0.79 (+33.90%) and the highest is $1.35 (+128.81%).
Price Target: $1.08 (+83.05%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2026.
Analyst Ratings
The average analyst rating for Aroa Biosurgery stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $0.77 → $0.79 | Buy | Maintains | $0.77 → $0.79 | +33.90% | May 27, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $1.12 → $1.09 | Buy | Maintains | $1.12 → $1.09 | +84.75% | May 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.16 → $1.35 | Buy | Maintains | $1.16 → $1.35 | +128.81% | May 3, 2026 |
Financial Forecast
Revenue This Year
120.66M
from 103.85M
Increased by 16.18%
Revenue Next Year
138.62M
from 120.66M
Increased by 14.89%
EPS This Year
0.02
from 0.02
Decreased by -10.66%
EPS Next Year
0.04
from 0.02
Increased by 135.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 122.5M | ||
| Avg | 120.7M | ||
| Low | 119.0M |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 17.9% | ||
| Avg | 16.2% | ||
| Low | 14.6% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 0.02 | ||
| Avg | 0.02 | ||
| Low | 0.01 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 7.2% | ||
| Avg | -10.7% | ||
| Low | -40.4% |